Pharmaceutical giant Eli Lilly has announced it is instituting a $35 dollar monthly cap on out-of-pocket insulin expenses. The company announced on Wednesday that it is moving forward with “price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or […]
source https://michaelantonio.biz/pharmaceutical-giant-eli-lilly-to-cap-monthly-out-of-pocket-insulin-costs-at-35/
No comments:
Post a Comment